e-Drug3D 880 |
BOSENTAN
|
cas 147536-97-8 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters F 50 PERCENT Solubility POORLY SOLUBLE IN WATER |
Target TARGET ENDOTHELIN RECEPTOR ENDOTHELIN-1 RECEPTOR PDB Ligand code = K86 (link to the list of PDB complexes) Download experimental 3D coordinates of K86 with added hydrogens |
DrugCentral Endothelin-1 receptor UNIPROT P25101 EDNRA Endothelin B receptor UNIPROT P24530 EDNRB |
Download SDF file | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide Formula: Calculated chemical properties: MW 551.62 NB_atoms 39 XLogP 4.20 PSA 131.052 NB_HD 2 NB_HA 11 fsp3 0.26 Lipinski(0=no;1=yes) 0 |
FDA NDA 021290 (label) INN (BOSENTAN) TRACLEER (ACTELION) APPROVAL= AP YEAR= 2001 NDA 209279 (label) INN (BOSENTAN) TRACLEER (ACTELION) APPROVAL= AP YEAR= 2017 NDA 205699 (pdf not found) INN (BOSENTAN) BOSENTAN (PH HEALTH) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 206002 (pdf not found) INN (BOSENTAN) BOSENTAN (ALVOGEN PINE BROOK) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 206987 (pdf not found) INN (BOSENTAN) BOSENTAN (NATCO PHARMA LTD) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 207110 (pdf not found) INN (BOSENTAN) BOSENTAN (WATSON LABS INC) APPROVAL= AP YEAR= 2019 NDA 207760 (pdf not found) INN (BOSENTAN) BOSENTAN (ZYDUS PHARMS) APPROVAL= AP YEAR= 2019 NDA 208695 (pdf not found) INN (BOSENTAN) BOSENTAN (HIKMA) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 209324 (pdf not found) INN (BOSENTAN) BOSENTAN (SUN PHARM) APPROVAL= AP YEAR= 2019 NDA 209742 (pdf not found) INN (BOSENTAN) BOSENTAN (AMNEAL PHARMS CO) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 205173 (pdf not found) INN (BOSENTAN) BOSENTAN (MYLAN) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 210342 (pdf not found) INN (BOSENTAN) BOSENTAN (CHARTWELL MOLECULAR) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 211461 (pdf not found) INN (BOSENTAN) BOSENTAN (ALEMBIC) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 213154 (pdf not found) INN (BOSENTAN) BOSENTAN (NATCO PHARMA LTD) APPROVAL= AP YEAR= 2025 NDA 213981 (pdf not found) INN (BOSENTAN) BOSENTAN (ZYDUS PHARMS USA INC) APPROVAL= TA YEAR= 2025 |
Other links: |